Asia-Pacific Americas Africa Europe Middle East

HETERO LABS LIMITED 7.A. A2 HETERO C.

Company Profile:

HETERO LABS LIMITED is a **factory (manufacturer)**.

Company Introduction:

Hetero Labs Limited is one of the largest generic pharmaceutical companies in India and a global leader in the manufacturing of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. Established in 1993, Hetero operates with a strong focus on research and development, manufacturing, and marketing a wide range of pharmaceutical products. The company is vertically integrated, possessing state-of-the-art manufacturing facilities approved by major global regulatory bodies. It is well-known for its contributions to various therapeutic areas, including antivirals, oncology, cardiovascular, neurology, and nephrology, among others. Hetero has a significant global presence, exporting its products to over 145 countries. The specific reference "7.A. A2 HETERO C." likely pertains to a particular manufacturing unit, plant, or internal division within the broader Hetero Labs Limited organization.

Enterprise Products

HETERO LABS LIMITED (including operations or divisions such as 7.A. A2 HETERO C.) primarily manufactures and sells a wide range of pharmaceutical products. These products are broadly categorized into:

1. Active Pharmaceutical Ingredients (APIs)

Hetero is one of the world's leading manufacturers and suppliers of Active Pharmaceutical Ingredients, which are the fundamental chemical compounds used in the production of finished pharmaceutical dosage forms. They produce APIs across various therapeutic categories for global markets.

2. Finished Dosage Formulations

Hetero develops, manufactures, and markets a comprehensive portfolio of finished pharmaceutical products in various dosage forms such as tablets, capsules, injections, oral solutions, and more. These formulations address a broad spectrum of therapeutic areas, including:

a. Antiretrovirals (ARVs)

Medicines for the treatment and management of HIV/AIDS.

b. Oncology Products

Drugs used in the treatment of various types of cancer.

c. Hepatology Products

Treatments for liver diseases, including Hepatitis C and Hepatitis B.

d. Cardiovascular Products

Medications for heart-related conditions and disorders of the circulatory system.

e. Neurology Products

Drugs for neurological disorders and conditions affecting the nervous system.

f. Nephrology Products

Medicines for kidney-related diseases and conditions.

g. Gastroenterology Products

Drugs for digestive system disorders and gastrointestinal ailments.

h. Diabetes Management Products

Medications for the treatment and management of diabetes.

i. Pain Management and Anti-inflammatory Products

Drugs designed to alleviate pain and reduce inflammation.

j. Anti-infectives

Antibiotics, antifungals, and antivirals used to treat various infections.

k. Immunology Products

Medications that modulate or suppress the immune system.

l. Respiratory Products

Drugs for conditions affecting the respiratory system, such as asthma and COPD.

m. Other Therapeutic Areas

Including products for urology, dermatology, women's health, and more.

Business Registration Information:

Manager:

Dr. B. Partha Saradhi Reddy (Chairman & Managing Director)

Phone:

+91-40-23704923 / 24 / 25 / 26

E-mail:

investors@hetero.com

Official Website:
Address:

Hetero Corporate, 7-2-A2, Industrial Estate, Sanathnagar, Hyderabad - 500 018, Telangana, INDIA.

This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.